Newsroom

Understanding the source and network of signals as the brain functions is a central goal of brain research. Now, Carnegie Mellon engineers have created a system for high-density EEG imaging of the origin and path of normal and abnormal brain signals.

The National Institutes of Health wasted no time and putting pandemic stimulus money to use. It launched RADx, a program to enlist industry in academia in a biomedical engineering approach to the pandemic.

Read more and listen to the interview at the Federal News Network.

Neuroengineers have created a tiny surgical implant that can electrically stimulate the brain and nervous system without using a battery or wired power supply.

Researchers are working on an entirely new way to detect blood clots, especially in pediatric patients.

An injectable electrode could prove a better way to ease chronic nerve pain than opioid painkillers or bulky and expensive implants, animal research suggests.

The podcast Epidemic, hosted by Dr. Celine Grounder and Robert Klain, featured episode 21: Are Antibodies the Holy Grail? Guests for this podcast episode are NIBIB's Kaitlyn Sadtler and NIAID's Matthew Memoli, who discuss the SARS-CoV-2 serology study they are conducting at NIH.

Listen and read a transcript.

Dr. Kaitlyn Sadtler of the National Institutes of Health still identifies with her younger self, running through the sprinklers and going to the Frederick County Fair. She earned a bachelor's degree in biological sciences and a Ph.D.and now is an investigator at the NIBIB at the NIH in Bethesda.

For more, visit WJLA-TV.

Researchers at the University of Wisconsin (UW) are adapting a minimally invasive, safer approach to electrically treat pain directly at the source as part of the NIH Helping to End Addiction Long-term (HEAL) Initiative.

To counter drug resistance, scientists must engineer new drugs to kill mutated cancer cells or pathogens. Now, Penn State engineers have developed a new approach for predicting which mutation has expanded the most in a population and should be targeted to design the most effective new drug.